Recently, promoter mutations in the telomerase reverse transcriptase encoding gene (TERT) have been consistently associated with more aggressive thyroid carcinomas [11], especially in the presence of BRAF mutation [12,13]. The gene discussed is BRAF; the disease is thyroid gland carcinoma.